Novel prevention strategies for bacterial infections in cirrhosis

Expert Opinion on Pharmacotherapy
Kathleen Yan, G García-Tsao

Abstract

Bacterial infections are a serious complication of cirrhosis, as they can lead to decompensation, multiple organ failure, and/or death. Preventing infections is therefore very relevant. Because gut bacterial translocation is their main pathogenic mechanism, prevention of infections is mostly based on the use of orally administered poorly absorbed antibiotics such as norfloxacin (selective intestinal decontamination). However, antibiotic prophylaxis leads to antibiotic resistance, limiting therapy and increasing morbidity and mortality. Prevention of bacterial infections in cirrhosis should therefore move away from antibiotics. This review focuses on various potentially novel methods to prevent infections in cirrhosis focusing on non-antibiotic strategies. The use of probiotics, nonselective intestinal decontamination with rifaximin, prokinetics and beta-blockers or fecal microbiota transplant as means of targeting altered gut microbiota, bile acids and FXR agonists are all potential alternatives to selective intestinal decontamination. Prokinetics and beta-blockers can improve intestinal motility, while bile acids and FXR agonists help by improving the intestinal barrier. Finally, granulocyte colony stimulating factor (G-CSF) a...Continue Reading

References

Jul 1, 1992·Gut·S A Sarker, K Gyr
Jan 1, 1992·Life Sciences·M Lyte, S Ernst
Jul 1, 1993·Journal of Hepatology·W R Caly, E Strauss
Jan 1, 1993·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·J W DingS Bengmark
Mar 1, 1996·Digestive Diseases and Sciences·F Casafont MorencosF Pons Romero
Jul 1, 1996·British Journal of Anaesthesia·J S Aranow, M P Fink
Apr 1, 1997·Digestive Diseases and Sciences·A M MadridC Defilippi
Oct 31, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C S ChangH Z Yeh
Mar 18, 1999·FEMS Microbiology Letters·P P FreestoneM Lyte
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B BernardT Poynard
Dec 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Pérez-ParamoJ Ortiz-Berrocal
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A PardoM A Gassull
Apr 17, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M BorzioA Sangiovanni
Sep 26, 2001·Applied and Environmental Microbiology·P MarteauG Corthier
Jan 31, 2002·World Journal of Gastroenterology : WJG·Osamu SaitohKen-ichi Katsu Ki
Feb 26, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vicente Lorenzo-ZúñigaMiquel Angel Gassull
Mar 13, 2003·World Journal of Gastroenterology : WJG·Shun-Cai ZhangWu-Nan Zhu
Jun 24, 2003·The American Journal of Gastroenterology·Steingerdur Anna GunnarsdottirEinar S Björnsson
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ming-Chih HouShou-Dong Lee
May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qing LiuStephen M Riordan
Jan 8, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nada RayesPeter Neuhaus
Jan 25, 2005·Journal of Hepatology·Hermann E WasmuthFrank Lammert
Feb 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Reiner Wiest, Guadalupe Garcia-Tsao
Apr 20, 2005·Journal of Gastroenterology and Hepatology·Bimaljit S SandhuShiv K Sarin
Dec 13, 2005·Nature Reviews. Drug Discovery·Mukesh K Jain, Paul M Ridker
Feb 14, 2006·Gastroenterology·Eamonn M M Quigley, Rodrigo Quera
Feb 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Takeshi InagakiSteven A Kliewer
Mar 24, 2009·Alimentary Pharmacology & Therapeutics·C PandeS K Sarin
Jun 11, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Marco SenzoloAndrew Kenneth Burroughs
Jun 27, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Miquel FalgueraUNKNOWN NAC-CALIDAD (Proyecto Integrado de Investigación de la Sociedad Española de Patología del Aparato Respiratorio sobre Infecci
Jul 21, 2009·Journal of Hepatology·Raza MalikRajiv Jalan
Oct 22, 2009·The American Journal of Gastroenterology·Jasmohan S BajajRaymond G Hoffmann
Nov 3, 2009·Current Opinion in Gastroenterology·Hoonmo L Koo, Herbert L DuPont
Mar 26, 2010·The New England Journal of Medicine·Nathan M BassWilliam P Forbes

❮ Previous
Next ❯

Citations

Apr 5, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Philip G FerstlClaudia Reinheimer
Dec 5, 2017·European Journal of Gastroenterology & Hepatology·Tao ZhangWei Jiang
Dec 5, 2019·Hepatology International·Vishal C Patel, Roger Williams
Mar 12, 2020·International Journal of Environmental Research and Public Health·Damian PiotrowskiAnna Boroń-Kaczmarska
Jul 30, 2020·BioMed Research International·Yong-Tao LiMei-Lian Peng
Jan 12, 2019·World Journal of Hepatology·Melisa DirchwolfAndrés Eduardo Ruf
Oct 22, 2019·Clinical Liver Disease·Guadalupe Garcia-Tsao
Aug 3, 2017·Scientific Reports·Christoph JüngstMarcin Krawczyk
Sep 12, 2020·Clinical and Molecular Hepatology·Beatriz Garcia Mendes, Bernd Schnabl
Oct 9, 2019·Archives of Medical Research·Maria-Angeles AllerJaime Arias

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.